European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“We are proud to have awarded two outstanding contributions at ICHNO2026!
Best Paper Award: Marc Oliva Bernal
REALKEY study: patient-reported outcomes in recurrent/metastatic head and neck cancer treated with first-line immunotherapy +/- chemotherapy
Best Poster Award: Gema Bruixola
ctDNA clearance after induction therapy as a predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer
Congratulations to both for their excellent work advancing research in head and neck cancer! You can view the papers in the abstract book.”
Other articles about ESTRO on OncoDaily.